WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- Investor RelationsAbout Us
- News & ResourcesAbout Us
WuXi XDC Launches New Commercial Manufacturing Facilities
WuXi XDC Launches New Commercial Manufacturing Facilities New commercial facilities offer one-stop manufacturing services for antibody intermediates, bioconjugate drug substance and drug product Doubled capacity provides greater support to the rapidly...WuXi XDC and Boostimmune Sign MOU for Integrated Services
SHANGHAI, Aug 11, 2023—WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the ADC and broader bioconjugate market, and Boostimmune, a biotech company dedicated to developing next-generation anti-cancer therapies...WuXi Biologics Announces Proposed Spin-off and Separate Listing of WuXi XDC on the Hong Kong Stock Exchange
Hong Kong, China, July 9, 2023 – WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the proposed spin-off and separate listing of its subsidiary WuXi XDC Cayman...WuXi Biologics and WuXi XDC Congratulate DualityBio on Entering Global Licensing and Collaboration Agreements with BioNTech to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics
SHANGHAI, China, April 17, 2023 — WuXi Biologics (“WuXi Bio”) (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) and its subsidiary WuXi XDC congratulate their partner DualityBio, a clinical-stage biotech company...WuXi XDC Congratulates EDDC on FDA Clearance of IND Application for First Made-in-Singapore Antibody-Drug Conjugate
SHANGHAI, March 9, 2023 – WuXi XDC (“XDC”), a leading global CRDMO company dedicated to end-to-end bioconjugate services, congratulates its partner, the Experimental Drug Development Centre (EDDC), Singapore’s national drug discovery and development platform...
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?